[{"AccountsPayableCurrent_0_Q2_USD":9825000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1729000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_1_Q2_pure":0.0,"DefinedContributionPlanEmployerMatchingContributionPercent_2_Q2_pure":0.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":2455000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-91000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":158059000.0,"OtherAssetsCurrent_0_Q2_USD":5261000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":442000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":20.32,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":27.65,"ProceedsFromStockOptionsExercised_2_Q2_USD":370000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":186000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-66638000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-40484000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":198000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":8707000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":25.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":137912000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1041000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":89667.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":6.45,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2834223.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":66000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-49077000.0,"DividendsCommonStock_2_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-28000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-66000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-91000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.11,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1758000.0,"OperatingLeasePayments_2_Q2_USD":393000.0,"OperatingLeasePayments_1_Q2_USD":205000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1399000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":569000.0,"OperatingLeaseLiability_0_Q2_USD":1968000.0,"OperatingLeaseCost_2_Q2_USD":347000.0,"OperatingLeaseCost_1_Q2_USD":173000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":104156000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":378000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":760000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":650000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":539000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":64000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2391000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-13000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":423000.0,"OtherAssetsNoncurrent_0_Q2_USD":357000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":7376000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":28000.0,"NetIncomeLoss_1_Q2_USD":-40393000.0,"NetIncomeLoss_2_Q2_USD":-66572000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49391000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-28000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":370000.0,"LiabilitiesCurrent_0_Q2_USD":15707000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":167329000.0,"Liabilities_0_Q2_USD":21321000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1305000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-66600000.0,"ProfitLoss_2_Q2_USD":-66572000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-40400000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10393000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.67,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.01,"CommonStockValue_0_Q2_USD":4000.0,"CommonStockSharesIssued_0_Q2_shares":40014519.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":158059000.0,"AssetsCurrent_0_Q2_USD":163320000.0,"Assets_0_Q2_USD":167329000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4956513.0,"AdditionalPaidInCapital_0_Q2_USD":378455000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-16000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18519000.0,"ResidualValueOfLeasedAsset_0_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1894000.0,"StockholdersEquity_0_Q2_USD":146008000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":35.3,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":14.35,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.59,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4931428.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":628000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":59000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":25778.0,"ShareBasedCompensation_2_Q2_USD":4665000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":48681000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":30059000.0,"PreferredStockValue_0_Q2_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-232435000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-67200000.0,"OperatingIncomeLoss_1_Q2_USD":-40452000.0,"OperatingExpenses_2_Q2_USD":67200000.0,"OperatingExpenses_1_Q2_USD":40452000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":5313000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":39862878.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":39972174.0,"PreferredStockSharesAuthorized_0_Q2_shares":5500000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]